CTLA4 and metastatic melanoma: However, combined with our present study, we believed that reproductive safety must be considered when checkpoint inhibitors were used during pregnancy, though it was reported that conception and viable twin pregnancy in a metastatic melanoma patient treated with CTLA-4 and PD-1 inhibitors [36].